Autologous neoantigen-specific T-cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous neoantigen-specific T-cell therapy, covering 2025-08-14 to 2025-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]